Orbimed Israel Biofund Gp Limited Partnership - Net Worth and Insider Trading
Orbimed Israel Biofund Gp Limited Partnership Net Worth
The estimated net worth of Orbimed Israel Biofund Gp Limited Partnership is at least $3 Million dollars as of 2024-05-09. Orbimed Israel Biofund Gp Limited Partnership is the 10% Owner of Chemomab Therapeutics Ltd and owns about 2,241,274 shares of Chemomab Therapeutics Ltd (CMMB) stock worth over $2 Million. Orbimed Israel Biofund Gp Limited Partnership is the 10% Owner of BiomX Inc and owns about 3,161,489 shares of BiomX Inc (PHGE) stock worth over $1 Million. Orbimed Israel Biofund Gp Limited Partnership is also the 10% Owner of Eledon Pharmaceuticals Inc and owns about 73,650 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $179,706. Besides these, Orbimed Israel Biofund Gp Limited Partnership also holds 9 Meters Biopharma Inc (NMTRQ) . Details can be seen in Orbimed Israel Biofund Gp Limited Partnership's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Orbimed Israel Biofund Gp Limited Partnership has not made any transactions after 2023-02-27 and currently still holds the listed stock(s).
Transaction Summary of Orbimed Israel Biofund Gp Limited Partnership
Orbimed Israel Biofund Gp Limited Partnership Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Orbimed Israel Biofund Gp Limited Partnership owns 6 companies in total, including 9 Meters Biopharma Inc (NMTRQ) , Eledon Pharmaceuticals Inc (ELDN) , and BiomX Inc (PHGE.U) among others .
Insider Ownership Summary of Orbimed Israel Biofund Gp Limited Partnership
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NMTRQ | 9 Meters Biopharma Inc | 2021-06-25 | 10 percent owner |
| ELDN | Eledon Pharmaceuticals Inc | 2020-12-02 | director & 10 percent owner |
| PHGE.U | BiomX Inc | 2019-12-18 | director & 10 percent owner |
 | | 2023-01-03 | 10 percent owner |
| | 2020-09-15 | director |
| | 2023-02-27 | director & 10 percent owner |
Orbimed Israel Biofund Gp Limited Partnership Latest Holdings Summary
Orbimed Israel Biofund Gp Limited Partnership currently owns a total of 4 stocks. Among these stocks, Orbimed Israel Biofund Gp Limited Partnership owns 2,241,274 shares of Chemomab Therapeutics Ltd (CMMB) as of January 3, 2023, with a value of $2 Million and a weighting of 54.71%. Orbimed Israel Biofund Gp Limited Partnership owns 3,161,489 shares of BiomX Inc (PHGE) as of February 27, 2023, with a value of $1 Million and a weighting of 39.24%. Orbimed Israel Biofund Gp Limited Partnership also owns 73,650 shares of Eledon Pharmaceuticals Inc (ELDN) as of December 2, 2020, with a value of $179,706 and a weighting of 6.05%. The other 1 stocks 9 Meters Biopharma Inc (NMTRQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Orbimed Israel Biofund Gp Limited Partnership
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd | 2023-01-03 | 2,241,274 | 0.73 | 1,624,924 |
| PHGE | BiomX Inc | 2023-02-27 | 3,161,489 | 0.37 | 1,165,325 |
| ELDN | Eledon Pharmaceuticals Inc | 2020-12-02 | 73,650 | 2.44 | 179,706 |
| NMTRQ | 9 Meters Biopharma Inc | 2021-06-25 | 1,597 | 0.00 | 0 |
Holding Weightings of Orbimed Israel Biofund Gp Limited Partnership
Orbimed Israel Biofund Gp Limited Partnership Form 4 Trading Tracker
According to the SEC Form 4 filings, Orbimed Israel Biofund Gp Limited Partnership has made a total of 1 transactions in Chemomab Therapeutics Ltd (CMMB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Chemomab Therapeutics Ltd is the sale of 336,900 shares on January 3, 2023, which brought Orbimed Israel Biofund Gp Limited Partnership around $1 Million.
According to the SEC Form 4 filings, Orbimed Israel Biofund Gp Limited Partnership has made a total of 4 transactions in BiomX Inc (PHGE) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in BiomX Inc is the acquisition of 348,000 shares on February 27, 2023, which cost Orbimed Israel Biofund Gp Limited Partnership around $87,000.
According to the SEC Form 4 filings, Orbimed Israel Biofund Gp Limited Partnership has made a total of 1 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the sale of 103,200 shares on December 2, 2020, which brought Orbimed Israel Biofund Gp Limited Partnership around $2 Million.
More details on Orbimed Israel Biofund Gp Limited Partnership's insider transactions can be found in the Insider Trading History of Orbimed Israel Biofund Gp Limited Partnership table.Insider Trading History of Orbimed Israel Biofund Gp Limited Partnership
- 1
Orbimed Israel Biofund Gp Limited Partnership Trading Performance
GuruFocus tracks the stock performance after each of Orbimed Israel Biofund Gp Limited Partnership's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Orbimed Israel Biofund Gp Limited Partnership is -19.44%. GuruFocus also compares Orbimed Israel Biofund Gp Limited Partnership's trading performance to market benchmark return within the same time period. The performance of stocks bought by Orbimed Israel Biofund Gp Limited Partnership within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Orbimed Israel Biofund Gp Limited Partnership's insider trading performs compared to the benchmark.
Performance of Orbimed Israel Biofund Gp Limited Partnership
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.18 | | | | | |
| Relative Return to S&P 500(%) | -10.47 | | | | | |
Orbimed Israel Biofund Gp Limited Partnership Ownership Network
Orbimed Israel Biofund Gp Limited Partnership Owned Company Details
What does 9 Meters Biopharma Inc do?
Who are the key executives at 9 Meters Biopharma Inc?
Orbimed Israel Biofund Gp Limited Partnership is the 10 percent owner of 9 Meters Biopharma Inc. Other key executives at 9 Meters Biopharma Inc include Chief Financial Officer Bethany Sensenig , director & Chief Executive Officer John Temperato , and Chief Financial Officer Edward J Sitar .
9 Meters Biopharma Inc (NMTRQ) Insider Trades Summary
Over the past 18 months, Orbimed Israel Biofund Gp Limited Partnership made no insider transaction in 9 Meters Biopharma Inc (NMTRQ). Other recent insider transactions involving 9 Meters Biopharma Inc (NMTRQ) include a net sale of 9,100 shares made by Bethany Sensenig ,
In summary, during the past 3 months, insiders sold 0 shares of 9 Meters Biopharma Inc (NMTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,100 shares of 9 Meters Biopharma Inc (NMTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,100 shares.
9 Meters Biopharma Inc (NMTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
9 Meters Biopharma Inc Insider Transactions
Orbimed Israel Biofund Gp Limited Partnership Mailing Address
Above is the net worth, insider trading, and ownership report for Orbimed Israel Biofund Gp Limited Partnership. You might contact Orbimed Israel Biofund Gp Limited Partnership via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 1022-4629.
Discussions on Orbimed Israel Biofund Gp Limited Partnership
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
